A study of spectral integration and normalization in NMR-based metabonomic analyses.

Metabonomics involves the quantitation of the dynamic multivariate metabolic response of an organism to a pathological event or genetic modification [J.K. Nicholson, J.C. Lindon, E. Holmes, Xenobiotica 29 (1999) 1181-1189]. The analysis of these data involves the use of appropriate multivariate statistical methods; Principal Component Analysis (PCA) has been documented as a valuable pattern recognition technique for 1H NMR spectral data [J.T. Brindle, H. Antti, E. Holmes, G. Tranter, J.K. Nicholson, H.W. Bethell, S. Clarke, P.M. Schofield, E. McKilligin, D.E. Mosedale, D.J. Grainger, Nat. Med. 8 (2002) 1439-1444; B.C. Potts, A.J. Deese, G.J. Stevens, M.D. Reily, D.G. Robertson, J. Theiss, J. Pharm. Biomed. Anal. 26 (2001) 463-476; D.G. Robertson, M.D. Reily, R.E. Sigler, D.F. Wells, D.A. Paterson, T.K. Braden, Toxicol. Sci. 57 (2000) 326-337; L.C. Robosky, D.G. Robertson, J.D. Baker, S. Rane, M.D. Reily, Comb. Chem. High Throughput Screen. 5 (2002) 651-662]. Prior to PCA the raw data is typically processed through four steps; (1) baseline correction, (2) endogenous peak removal, (3) integration over spectral regions to reduce the number of variables, and (4) normalization. The effect of the size of spectral integration regions and normalization has not been well studied. The variability structure and classification accuracy on two distinctly different datasets are assessed via PCA and a leave-one-out cross-validation approach under two normalization approaches and an array of spectral integration regions. The first dataset consists of urine from 15 male Wistar-Hannover rats dosed with ANIT measured at five time points, mimicking drug-induced cholangiolitic hepatitis [D.G. Robertson, M.D. Reily, R.E. Sigler, D.F. Wells, D.A. Paterson, T.K. Braden, Toxicol. Sci. 57 (2000) 326-337; J.P. Shockcor, E. Holmes, Curr. Top. Med. Chem. 2 (2002) 35-51; N.J. Waters, E. Holmes, A. Williams, C.J. Waterfield, R.D. Farrant, J.K. Nicholson, Chem. Res. Toxicol. 14 (2001) 1401-1412]. The second data is serum samples from young male C57BL/6 mice subjected to instillation of pancreatic elastase producing emphysema type symptoms [C. Kuhn, S.Y. Yu, M. Chraplyvy, H.E. Linder, R.M. Senior, Lab. Invest. 34 (1976) 372-380; C. Kuhn, R.M. Senior, Lung 155 (1978) 185-197]. This study indicates that independent of the normalization method the classification accuracy achieved from metabonomic studies is not highly sensitive to the size of the spectral integration region. Additionally, both datasets scaled to mean zero and unity variance (auto-scaled) have higher variability within classification accuracy over spectral integration window widths than data scaled to the total intensity of the spectrum. Of the top 10 latent variables for the ANIT dataset the auto-scale normalization has standard deviations larger than the total-scale in seven cases. In the case of the elastase all standard deviations are larger for the auto-scaling.

[1]  John C. Lindon,et al.  NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the rat. , 2002 .

[2]  M. Tanner,et al.  Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E Holmes,et al.  Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. , 1998, Chemical research in toxicology.

[4]  E Holmes,et al.  NMR and pattern recognition studies on the time-related metabolic effects of alpha-naphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. , 2001, Chemical research in toxicology.

[5]  B Suki,et al.  Roles of mechanical forces and collagen failure in the development of elastase-induced emphysema. , 2001, American journal of respiratory and critical care medicine.

[6]  R. Senior,et al.  The role of elastases in the development of emphysema , 1978, Lung.

[7]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[8]  Elaine Holmes,et al.  Metabonomic applications in toxicity screening and disease diagnosis. , 2002, Current topics in medicinal chemistry.

[9]  M. Reily,et al.  In vivo toxicity screening programs using metabonomics. , 2002, Combinatorial chemistry & high throughput screening.

[10]  M. Reily,et al.  NMR of biofluids and pattern recognition: assessing the impact of NMR parameters on the principal component analysis of urine from rat and mouse. , 2001, Journal of pharmaceutical and biomedical analysis.

[11]  R. Senior,et al.  The induction of emphysema with elastase. II. Changes in connective tissue. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[12]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[13]  J. Keane,et al.  Severity of Elastase-Induced Emphysema Is Decreased in Tumor Necrosis Factor-α and Interleukin-1β Receptor-Deficient Mice , 2002, Laboratory Investigation.

[14]  Celia M. Henry.  NEW 'OME' IN TOWN: The "metabonome" provides real-world information about drug toxicity, gene function , 2002 .

[15]  M. Nugent,et al.  Transcriptional regulation of pulmonary elastin gene expression in elastase-induced injury. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[16]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[17]  M. Reily,et al.  Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.